BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 791476)

  • 1. Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures.
    Dellinger CT; Miale TD
    Cancer; 1976 Oct; 38(4):1843-6. PubMed ID: 791476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase.
    King OY; Wilbur JR; Mumford DM; Sutow WW
    Cancer; 1974 Mar; 33(3):611-4. PubMed ID: 4592901
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma.
    Evans WE; Tsiatis A; Rivera G; Murphy SB; Dahl GV; Denison M; Crom WR; Barker LF; Mauer AM
    Cancer; 1982 Apr; 49(7):1378-83. PubMed ID: 7037164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
    Ohnuma T; Holland JF; Meyer P
    Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase.
    Billett AL; Carls A; Gelber RD; Sallan SE
    Cancer; 1992 Jul; 70(1):201-6. PubMed ID: 1606543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.
    Vrooman LM; Supko JG; Neuberg DS; Asselin BL; Athale UH; Clavell L; Kelly KM; Laverdière C; Michon B; Schorin M; Cohen HJ; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2010 Feb; 54(2):199-205. PubMed ID: 19672973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients.
    Wang B; Relling MV; Storm MC; Woo MH; Ribeiro R; Pui CH; Hak LJ
    Leukemia; 2003 Aug; 17(8):1583-8. PubMed ID: 12886246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Ridgway D; Neerhout RC; Bleyer A
    Cancer; 1989 Feb; 63(3):561-3. PubMed ID: 2643458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.
    Duval M; Suciu S; Ferster A; Rialland X; Nelken B; Lutz P; Benoit Y; Robert A; Manel AM; Vilmer E; Otten J; Philippe N
    Blood; 2002 Apr; 99(8):2734-9. PubMed ID: 11929760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanism.
    Fabry U; Körholz D; Jürgens H; Göbel U; Wahn V
    Pediatr Res; 1985 Apr; 19(4):400-8. PubMed ID: 3858789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
    Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The feasibility of Erwinia asparaginase for pediatric patients who developed an allergic reaction to E.coli asparaginase during treatment of acute lymphoblastic leukemia].
    Takahashi H; Koh K; Kato M; Isobe K; Yasui N; Mori M; Akiyama K; Kikuchi A; Hanada R
    Rinsho Ketsueki; 2013 Apr; 54(4):370-7. PubMed ID: 23666219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erwinia asparaginase in pediatric acute lymphoblastic leukemia.
    Salzer W; Seibel N; Smith M
    Expert Opin Biol Ther; 2012 Oct; 12(10):1407-14. PubMed ID: 22946493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
    Rau RE; Dreyer Z; Choi MR; Liang W; Skowronski R; Allamneni KP; Devidas M; Raetz EA; Adamson PC; Blaney SM; Loh ML; Hunger SP
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29090524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study.
    Wacker P; Land VJ; Camitta BM; Kurtzberg J; Pullen J; Harris MB; Shuster JJ;
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):627-32. PubMed ID: 17805038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified pharmacokinetics of I-asparaginase from E coli by formation of specific antibodies to I-Asparaginase of different immunoglobulin classes in children with acute lymphocytic leukemia.
    Wahn V; Fabry U; Körholz D; Reinhardt D; Jürgens H; Göbel U
    Pediatr Pharmacol (New York); 1983; 3(3-4):303-11. PubMed ID: 6377216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparaginase: molecular and enzymic requirements for use as an antileukaemia agent.
    Wade HE
    J Gen Microbiol; 1971 Mar; 65(3):x-xi. PubMed ID: 4997395
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.
    Vrooman LM; Kirov II; Dreyer ZE; Kelly M; Hijiya N; Brown P; Drachtman RA; Messinger YH; Ritchey AK; Hale GA; Maloney K; Lu Y; Plourde PV; Silverman LB
    Pediatr Blood Cancer; 2016 Feb; 63(2):228-33. PubMed ID: 26376459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetic studies of three asparaginase preparations.
    Asselin BL; Whitin JC; Coppola DJ; Rupp IP; Sallan SE; Cohen HJ
    J Clin Oncol; 1993 Sep; 11(9):1780-6. PubMed ID: 8355045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.